BEVACIPTIN bevacizumab 100 mg/4 mL concentrated solution for infusion vial Cancelled under Section 30(1)(c) of the Act
Product name
BEVACIPTIN bevacizumab 100 mg/4 mL concentrated solution for infusion vial
Sponsor
ARTG details
- 347292
Date of effect
Decision type
Cancelled under Section 30(1)(c) of the Act